Skip to main content
SpringerLink
Log in

Low Direct Cytotoxicity and Cytoprotective Effects of Nitric Oxide Releasing Indomethacin

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Nitric oxide (NO) releasing non-steroidal anti-inflammatory drugs (NSAIDs) have shown a marked reduction of gastrointestinal side effects and we here examined the cytotoxicity of NCX 530 (NO-indomethacin). Under conditions where indomethacin clearly induced both necrosis and apoptosis, NCX 530 induced neither. NCX 530 protected cells from celecoxib-induced necrosis and apoptosis. NCX 530 partially suppressed celecoxib-dependent membrane permeabilization and an inhibitor for guanylate cyclase suppressed the cytoprotective effect of NCX 530 against celecoxib. In vivo, NCX 530 alone produced fewer gastric lesions in rats than did indomethacin. A combination of the oral administration of celecoxib together with the intraperitoneal administration of indomethacin, but not of NCX 530, clearly resulted in the production of gastric lesions. The low direct cytotoxicity and the cytoprotective effect of NCX 530 observed in vitro may also act in vivo, thus ensuring that NCX 530 is safe for use on the gastric mucosa.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Smalley WE, Ray WA, Daugherty JR, Griffin MR: Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol 141:539–545, 1995

    PubMed  Google Scholar 

  2. Hawkey CJ: Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology 119:521–535, 2000

    Article  PubMed  Google Scholar 

  3. Barrier CH, Hirschowitz BI: Controversies in the detection and management of nonsteroidal antiinflammatory drug-induced side effects of the upper gastrointestinal tract. Arthritis Rheum 32:926–932, 1989

    PubMed  Google Scholar 

  4. Gabriel SE, Jaakkimainen L, Bombardier C: Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 115:787–796, 1991

    PubMed  Google Scholar 

  5. Fries JF, Miller SR, Spitz PW, Williams CA, Hubert HB, Bloch DA: Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use. Gastroenterology 96:647–655, 1989

    PubMed  Google Scholar 

  6. Kurata JH, Abbey DE: The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations. J Clin Gastroenterol 12:260–266, 1990

    PubMed  Google Scholar 

  7. Singh G: Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med 105:31S–38S, 1998

    Article  PubMed  Google Scholar 

  8. Vane JR, Botting RM: Mechanism of action of anti-inflammatory drugs. Scand J Rheumatol (Suppl 102):9–21, 1996

    Google Scholar 

  9. Miller TA: Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. Am J Physiol 245:G601–G623, 1983

    Google Scholar 

  10. Ligumsky M, Golanska EM, Hansen DG, Kauffman GJ: Aspirin can inhibit gastric mucosal cyclo-oxygenase without causing lesions in rat. Gastroenterology 84:756–761, 1983

    PubMed  Google Scholar 

  11. Ligumsky M, Sestieri M, Karmeli F, Zimmerman J, Okon E, Rachmilewitz D: Rectal administration of nonsteroidal antiinflammatory drugs. Effect on rat gastric ulcerogenicity and prostaglandin E2 synthesis. Gastroenterology 1245–1249, 1990

  12. Lichtenberger LM: Where is the evidence that cyclooxygenase inhibition is the primary cause of nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal injury? Topical injury revisited. Biochem Pharmacol 61:631–637, 2001

    PubMed  Google Scholar 

  13. Lichtenberger LM, Wang ZM, Romero JJ, Ulloa C, Perez JC, Giraud MN, Barreto JC: Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury. Nat Med 1:154–158, 1995

    Article  PubMed  Google Scholar 

  14. Somasundaram S, Rafi S, Hayllar J, Sigthorsson G, Jacob M, Price AB, Macpherson A, Mahmod T, Scott D, Wrigglesworth JM, Bjarnason I: Mitochondrial damage: a possible mechanism of the “topical” phase of NSAID induced injury to the rat intestine. Gut 41:344–353, 1997

    PubMed  Google Scholar 

  15. Tomisato W, Tsutsumi S, Rokutan K, Tsuchiya T, Mizushima T: NSAIDs induce both necrosis and apoptosis in guinea pig gastric mucosal cells in primary culture. Am J Physiol Gastrointest Liver Physiol 281:G1092–G1100, 2001

    Google Scholar 

  16. Tomisato W, Tsutsumi S, Hoshino T, Hwang HJ, Mio M, Tsuchiya T, Mizushima T: Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions. Biochem Pharmacol 67:575–585, 2004

    Article  PubMed  Google Scholar 

  17. Takeuchi K, Mizoguchi H, Araki H, Komoike Y, Suzuki K: Lack of gastric toxicity of nitric oxide-releasing indomethacin, NCX-530, in experimental animals. Dig Dis Sci 46:1805–1818, 2001

    Article  PubMed  Google Scholar 

  18. Hawkey CJ, Jones JI, Atherton CT, Skelly MM, Bebb JR, Fagerholm U, Jonzon B, Karlsson P, Bjarnason IT: Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans. Gut 52:1537–1542, 2003

    Article  PubMed  Google Scholar 

  19. Johnson AJ, Hsu AL, Lin HP, Song X, Chen CS: The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks. Biochem J 366:831–837, 2002

    PubMed  Google Scholar 

  20. Fiorucci S, Santucci L, Gresele P, Faccino RM, Del Soldato P, Morelli A: Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study. Gastroenterology 124:600–607, 2003

    Article  PubMed  Google Scholar 

  21. Wallace JL, Reuter B, Cicala C, McKnight W, Grisham MB, Cirino G: Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology 107:173–179, 1994

    PubMed  Google Scholar 

  22. Wallace JL, McKnight W, Del Soldato P, Baydoun AR, Cirino G: Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative. J Clin Invest 96:2711–2718, 1995

    PubMed  Google Scholar 

  23. Wallace JL, Miller MJ: Nitric oxide in mucosal defense: a little goes a long way. Gastroenterology 119:512–520, 2000

    Article  PubMed  Google Scholar 

  24. Johal K, Hanson PJ: Opposite effects of flurbiprofen and the nitroxybutyl ester of flurbiprofen on apoptosis in cultured guinea-pig gastric mucous cells. Br J Pharmacol 130:811–818, 2000

    Article  PubMed  Google Scholar 

  25. Fiorucci S, Santucci L, Federici B, Antonelli E, Distrutti E, Morelli O, Renzo GD, Coata G, Cirino G, Soldato PD, Morelli A: Nitric oxide-releasing NSAIDs inhibit interleukin-1beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNFalpha. Aliment Pharmacol Ther 13:421–435, 1999

    Article  PubMed  Google Scholar 

  26. Hirakawa T, Rokutan K, Nikawa T, Kishi K: Geranylgeranylacetone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology 111:345–357, 1996

    Article  PubMed  Google Scholar 

  27. Tomisato W, Takahashi N, Komoto C, Rokutan K, Tsuchiya T, Mizushima T: Geranylgeranylacetone protects cultured guinea pig gastric mucosal cells from indomethacin. Dig Dis Sci 45:1674–1679, 2000

    Article  PubMed  Google Scholar 

  28. Tomisato W, Hoshino T, Tsutsumi S, Tsuchiya T, Mizushima T: Maturation-associated increase in sensitivity of cultured guinea pig gastric pit cells to hydrogen peroxide. Dig Dis Sci 47:2125–2133, 2002

    Article  PubMed  Google Scholar 

  29. Tsutsumi S, Tomisato W, Takano T, Rokutan K, Tsuchiya T, Mizushima T: Gastric irritant-induced apoptosis in guinea pig gastric mucosal cells in primary culture. Biochim Biophys Acta 1589:168–180, 2002

    Article  PubMed  Google Scholar 

  30. Katsu T: Application of calcein-loaded liposomes for the determination of membrane channel size. Biol Pharm Bull 22:978–980, 1999

    PubMed  Google Scholar 

  31. New RRC: Liposomes: A Practical Approach. Oxford: IRL Press, 1990, pp 105–161.

    Google Scholar 

  32. Tomisato W, Tanaka K, Katsu T, Kakuta H, Sasaki K, Tsutsumi S, Hoshino T, Aburaya M, Li D, Tsuchiya T, Suzuki K, Yokomizo K, Mizushima T: Membrane permeabilization by non-steroidal anti-inflammatory drugs. Biochem Biophys Res Commun 323:1032–1039, 2004

    Article  PubMed  Google Scholar 

  33. Lee BS, Chen J, Angelidis C, Jurivich DA, Morimoto RI: Pharmacological modulation of heat shock factor 1 by antiinflammatory drugs results in protection against stress-induced cellular damage. Proc Natl Acad Sci USA 92:7207–7211, 1995

    PubMed  Google Scholar 

  34. Tsutsumi S, Gotoh T, Tomisato W, Mima S, Hoshino T, Hwang HJ, Takenaka H, Tsuchiya T, Mori M, Mizushima T: Endoplasmic reticulum stress response is involved in nonsteroidal anti-inflammatory drug-induced apoptosis. Cell Death Differ, 2004

  35. Kim YM, Talanian RV, Billiar TR: Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 272:31138–31148, 1997

    Google Scholar 

  36. Brunner F, Stessel H, Kukovetz WR: Novel guanylyl cyclase inhibitor, ODQ reveals role of nitric oxide, but not of cyclic GMP in endothelin-1 secretion. FEBS Lett 376:262–266, 1995

    Article  PubMed  Google Scholar 

  37. Fiorucci S, Antonelli E, Santucci L, Morelli O, Miglietti M, Federici B, Mannucci R, Del Soldato P, Morelli A: Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats. Gastroenterology 116:1089–1106, 1999

    PubMed  Google Scholar 

  38. Yeh RK, Chen J, Williams JL, Baluch M, Hundley TR, Rosenbaum RE, Kalala S, Traganos F, Benardini F, del Soldato P, Kashfi K, Rigas B: NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit colon cancer cell growth more potently than traditional NSAIDs: a general pharmacological property? Biochem Pharmacol 67:2197–2205, 2004

    Article  PubMed  Google Scholar 

  39. Mizoguchi H, Hase S, Tanaka A, Takeuchi K: Lack of small intestinal ulcerogenecity of nitric oxide-releasing indomethacin, NCX-530, in rats. Aliment Pharmacol Ther 15:257–267, 2001

    Article  PubMed  Google Scholar 

  40. Mukherjee D, Nissen SE, Topol EJ: Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 286:954–959, 2001

    PubMed  Google Scholar 

  41. Mukherjee D: Selective cyclooxygenase-2 (COX-2) inhibitors and potential risk of cardiovascular events. Biochem Pharmacol 63:817–821, 2002

    Article  PubMed  Google Scholar 

  42. McAdam BF, Catella LF, Mardini IA, Kapoor S, Lawson JA, Fitzgerald GA: Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA 96:272–277, 1999

    Article  PubMed  Google Scholar 

  43. Catella LF, McAdam B, Morrison BW, Kapoor S, Kujubu D, Antes L, Lasseter KC, Quan H, Gertz BJ, Fitzgerald GA: Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther 289:735–741, 1999

    PubMed  Google Scholar 

  44. Belton O, Byrne D, Kearney D, Leahy A, Fitzgerald DJ: Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Circulation 102:840–845, 2000

    PubMed  Google Scholar 

  45. Hennan JK, Huang J, Barrett TD, Driscoll EM, Willens DE, Park AM, Crofford LJ, Lucchesi BR: Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries. Circulation 104:820–825, 2001

    PubMed  Google Scholar 

  46. Dowd NP, Scully M, Adderley SR, Cunningham AJ, Fitzgerald DJ: Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo. J Clin Invest 108:585–590, 2001

    Article  PubMed  Google Scholar 

  47. Katsu T, Kobayashi H, Hirota T, Fujita Y, Sato K, Nagai U: Structure–activity relationship of gramicidin S analogues on membrane permeability. Biochim Biophys Acta 899:159–170, 1987

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, 862-0973

    Wataru Tomisato Phd, Ken-Ichiro Tanaka Bs, Shinji Tsutsumi Phd, Tatsuya Hoshino Bs, Kazumi Yokomizo Phd, Keitarou Suzuki Phd, Tohru Mizushima Phd & Tohru Mizushima Dr

  2. Faculty of Pharmaceutical Sciences, Okayama University, Okayama, 700-8530, Japan

    Wataru Tomisato Phd & Takashi Katsu Phd

  3. Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, 862-0973, Japan

    Tohru Mizushima Dr

Authors
  1. Wataru Tomisato Phd
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ken-Ichiro Tanaka Bs
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shinji Tsutsumi Phd
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tatsuya Hoshino Bs
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kazumi Yokomizo Phd
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Keitarou Suzuki Phd
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Takashi Katsu Phd
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tohru Mizushima Phd
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tohru Mizushima Dr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tohru Mizushima Dr.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tomisato, W., Tanaka, KI., Tsutsumi, S. et al. Low Direct Cytotoxicity and Cytoprotective Effects of Nitric Oxide Releasing Indomethacin. Dig Dis Sci 50, 1927–1937 (2005). https://doi.org/10.1007/s10620-005-2963-4

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-005-2963-4

Key Words

Search

Navigation